Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1462, 2004-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Liposomal doxorubicin effective for advanced breast cancer
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :
Access to resources
Recommend
Vinorelbine/epirubicin vs AC in operable breast cancer
Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. :
Doxorubicin liposomal cost saving vs topotecan in ovarian cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 430, 2003-01 ,pp. :
Doxorubicin + docetaxel vs standard chemo in breast cancer
Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. :
Doxorubicin liposomal + docetaxel: efficacy in metastatic breast cancer?
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :